{"name":"Hummingbird Bioscience","slug":"hummingbird-bioscience","ticker":"","exchange":"","domain":"hummingbird.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxOanRRaXM2TkxObmtBTHZRdXJLcjNhcU5OS2JwVG1nQTNSVktpaG10akFpUFRmSTdUYUlPTDRObkVNeDA5cmItS0JTdmM4X1Z5Q1JoZ1ZISTNOV01BRmQwYjhZOWYzS3dSa2hHQzJVLXQwRjZ5R1N0ODNkdm43R3RlaGJR?oc=5","date":"2025-07-30","type":"pipeline","source":"bain.com","summary":"Empowering Biotech Innovation in Asia-Pacific - bain.com","headline":"Empowering Biotech Innovation in Asia-Pacific","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxPLVg2eEJGTzJEVUJ2Y1lhRnc5SXdWM1htajFPVE5LTGxUNk8tQWh2N3RFaGE4X01XY3A3OUdIcVd6aDdxdnJ1MEUtMFh6UGJqaUp6bHNwb29mVDU3X0hoS3VTdHdkazdLajN4WnRhSXFLSW9MNjhWZmRRZUJ3dlRYelJvSkhjX3hOcW1mZGpZa1N2SXJWX2FseTVySzZtdWNMSkcxV3Zybw?oc=5","date":"2025-06-27","type":"deal","source":"Fierce Pharma","summary":"Fierce Pharma Asia—Vor-RemeGen, Otsuka-Harbour autoimmune deals; Datroway's lung cancer nod - Fierce Pharma","headline":"Fierce Pharma Asia—Vor-RemeGen, Otsuka-Harbour autoimmune deals; Datroway's lung cancer nod","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxQS041aHlmZGxQVnZjbG1sZkgwYmYxak12TDk5NFBxZi16WHliREtYLUQ2dXR2Z3R2MVY0OTJEV21qdEJxbmE4M1c3TllpX3Z5eU1VWldtUF9VSGJkRkh5eEtCVjNBRF83dEZUTkZwUFJ1LWhfVXZQeWdUU1RMWDUwLWxGLTZQcmp2Y2dnWUpORUtXMzA3TDVRLXlUV3dNTklmcjkzV2MwbXc4Z1k?oc=5","date":"2025-06-26","type":"trial","source":"Fierce Biotech","summary":"Hummingbird uses VISTA buzz to secure $290M pact for phase 2-ready tumor drug - Fierce Biotech","headline":"Hummingbird uses VISTA buzz to secure $290M pact for phase 2-ready tumor drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYEFVX3lxTE5XZ3NjaDJxQ29lZHZlbTNVdXQzOXFGTENNQTVGSFBPWEZEZUpOWjBGT0JHaEoyY1lTU0Q0a01ELW9nZ3Y4bUZtWFFxejRxQ1hvXzRSV1RIMXFaU1ZYZW12Mw?oc=5","date":"2025-03-12","type":"pipeline","source":"The Pharma Letter","summary":"Callio Therapeutics - The Pharma Letter","headline":"Callio Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxNU0ZXZWxUUENwUmhLY1FpUFZPUmRIZjZEVElpZmV4eERXM2R1ZERrYUdwSFV2WG9BMDZVU2g1TkxaaUFNTGQ3LVgzYzdFM2lsZ3JiWWNaZEJ4ZzlBU19UZXJacFUyUFJpaFE3ZmJhRVlZbzRiOXlvRGlTWUgwNF91WHU5TkxsWjRCcmt6dWw3WGhza0hQeUhyX2VB?oc=5","date":"2025-03-04","type":"pipeline","source":"The Pharma Letter","summary":"Frazier launches Callio with $187 million for ADCs - The Pharma Letter","headline":"Frazier launches Callio with $187 million for ADCs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE1ZWV9BdERSRko2enMyd0NnTjNmUkNHVlVIQzRCdTBXdm9NRGVmb3dwQkxtMF95Yi1ERUl2aDB4QjBVY1o1YmUxb2tuSDFudkY5aFlB?oc=5","date":"2025-03-03","type":"deal","source":"FirstWord Pharma","summary":"Callio debuts with $187M, Hummingbird deal to craft dual-payload ADCs - FirstWord Pharma","headline":"Callio debuts with $187M, Hummingbird deal to craft dual-payload ADCs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxNNjluSU9fejFLck1uOGs4TUJMX3FwMHJOYm9sUHpKS0R5MHBQU3hpZ3hTYy1hb3E3RlE5YUd5RzVFdnVBTUpYWWxodFdsMDhmdkRDQUFzNHNwbHVVaWdOdndLS1FaRW9Ea3pyTW8yOENkV3B3RDUwNllINHFZVUI3MFptUTZhQUxIdThzTGZR?oc=5","date":"2025-03-03","type":"pipeline","source":"BioPharma Dive","summary":"Biotech startup pulls in $187M to make ‘multi-payload’ ADCs - BioPharma Dive","headline":"Biotech startup pulls in $187M to make ‘multi-payload’ ADCs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxQWDhwWnpzNWxRek9mQXhVWkRyNEZJQjFfX0FRNDR6aEZOUk15Z3BTbVF4NllMLXJXNFFzdGxSMUs5YTRHODZ0NU5lVDhIbmkycEJhT2lDcHVndklCdG1uc3pvUllaT1ZvNmRyWFNXc3FuT3pXbWtSaVNLM2xjQi1OM3poQUpDem9PQW1VMmJYWE8yTjhKV19JUA?oc=5","date":"2025-03-03","type":"pipeline","source":"Contract Pharma","summary":"Callio Therapeutics Launches with $187M Series A - Contract Pharma","headline":"Callio Therapeutics Launches with $187M Series A","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxQdGtmbFlWVVNaMWZlSG9wSVJnMGluRXdTb3BsNWtzd2lHZGVGVS1XYVA0Zmx0eVZwNWxFRVQzUXM2bk5BdnNZQ0lfcEdpclRwMXdhZy1XampCU0dpRlNzRlJmd1liUUZYNzVucWE3VENZLXVvQXNYR1VVVVVfSGtCOV9xWmEzOV9Xa2IzVWJSVHhLQmFLSUQzNw?oc=5","date":"2024-07-29","type":"pipeline","source":"Contract Pharma","summary":"Hummingbird Bioscience Appoints New CMO and COO - Contract Pharma","headline":"Hummingbird Bioscience Appoints New CMO and COO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3gFBVV95cUxQbU1SeEFueUJ5QWRQWkpyNGtKTkFWcjR1UEZmSGxiQWtFUUE5c3BpbUcydFJvSmNMTURkOE0tZUJJdWw2SWdvSWpwM1E4RVpuby00Wk1GbVRMaDJ5VWw4X1NkX3VQU0ZUYTNkVGRBc1NfYk9ySktUX2VyekdKekxDWTJlRFRqQ1Ixdm9BN2JwMlhMckVubDFYQkwxM3NqY0d6bm9vNmtiMmR4c242Zlh0c3B6eDNoaEhVNWMweGdSY0E1bkpyRzZsTkRwaTk5R0o2dV9vMDJPakJTZzYzT0E?oc=5","date":"2023-05-09","type":"pipeline","source":"BioPharma APAC","summary":"Hummingbird Bioscience to showcase preclinical proof of concept for novel autoimmune disease antibody - BioPharma APAC","headline":"Hummingbird Bioscience to showcase preclinical proof of concept for novel autoimmune disease antibody","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxPajl5WTF3UUJpa2Npd2JNelRmRzZpdndqNmhaZnZzWUw2Zm9HZU80LWRjX0UyMFFMQ1U4OWgzYWZCZVRzdXN3emx2aDR3Y3A5Smt6eEs1VmNkLTc5SU54NjdXajBiZWIzdXo3dDVyOV9oeDI4M19NRlBOcHYxeVlmT3UwdXNXX1dHZkVfbVc2MjVlek1aanlEVUdtTUY?oc=5","date":"2023-01-09","type":"pipeline","source":"Labiotech.eu","summary":"Hummingbird Bioscience and Synaffix to develop ADC program - Labiotech.eu","headline":"Hummingbird Bioscience and Synaffix to develop ADC program","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxNRWItYmZsX0NSS1BJSG1rYlRBZkhhZmNwMmV2aGpqSzFaOUFqcS01eW9nUm5FMkVqWERldTMyZmd4ZVJ4LXVyTkMzdHVmdWZtLW01MkNxejIyY2NMMmVuN2FPU1pTT2dtbFNyT0ZhT2lVTmxaUkZHcE1DYVZjR3BKTEc5UXF4WXJ0SWdKd1FSb2xLempuUnpQOG5kaTlDalB0dUFqag?oc=5","date":"2021-05-18","type":"pipeline","source":"Fierce Biotech","summary":"Hummingbird Bioscience buzzes with $125M series C led by Novo Holdings - Fierce Biotech","headline":"Hummingbird Bioscience buzzes with $125M series C led by Novo Holdings","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}